C'mon, sell Embeda bitches. Just pretend you're a street dealer selling not just morphine but the best morphine that ever was.
remember its LESS abusive than regular morphine...but it still could be abused by a very creative/resourceful drug
if someone knows how to sell this dog I would like to know. Nothing like getting a doctor to write it but patients cant find it stocked at a pharmacy. But I better not "make excuses" and need to execute better. Whatever!
Aww, man! Just tell the public that Embeda is reusable. You soak the capsules, dissolve the morphine, and send the little pellets back to Pfizer for a refund! Right Limpwick?
"Mr. Smith, take Embeda and the abuse deterrant capsules will protect you from yourself." "Hey Doc! Fuck you and give me what I want or I'll find another Doc!"
Uh, yeh, Embeda is a nightmare to sell. Remember Dr., It's LESS abusive due to the abuse deterrent pellets that can result in death if chewed or tampered, so you can rest assured that you are protecting your patient Dr. How many patients EXPERIENCES can I count on from you TODAY ? Exit stage left....
This medicine sold VERY well under King pharma. Millions of Dollars in sales. IT NEEDS COVERAGE. NOW.
So Pfizer spent billions taking over King for a million dollar drug???? That should be a case study in business school on what NOT to do.
NO! Pfizer CANNOT claim that Embeda has a "protective effect" against respiratory depression and/or "death" as King Pharmaceuticals was doing when it got acquired by Pfizer. Pfizer abandoned the "protective effect" idea because attenuating respiratory depression wouldn't generate ANY additional revenue from insurers. Don't remember that call? Ask Alan Litwack, Sean Donevan, Lisa Milandro, and Bimal Malhotra. They made the call. And it's the same sad story with oxycodone (ALO-02)!!!
That's good..missed that phone call. Thank THE LORD! I was off that boat by the time PFE took over. GOOD SELLING!
Between Embeda, Oxecta, Remoxy, and AL-02, that would explain how Pfizer took a potential billion dollar franchise and turned it into a million dollar franchise. Don't hound me about not selling it.
The purchase of King by Pfizer is the poster child for buy low, sell high. They sold right at the peak of the abuse deterrence wave. No one thought about the fact that a payer freight train was coming. You can't make billions in a market that is virtually all generic. OxyContin cratering big time. Plus payers don't give a crap about abuse deterrence. At least, not when it means paying $100 for a branded script vs. $10 for generic.
Spoken like a true-blue Pfizer Vice President or one of the Jack-ass middle managers named above. You go NY Opioid Team!!! You rock!!!
Look. The opioid line could have been developed as being safer but NPT with Oliver Brandicort decided against the concept. So you see, there was little the management team could. We are exhonorabated. Sell it as is. Thank you.
Do Pfizer VPs really talk that way? If so, then that's your problem! Sounds like a disgruntled investor.
Yeah, that's right. It's a disgruntled investor, one who interacts with GCMT and NPT. Yeah, that's it. It's not someone from within Pfizer who knows about the internal politics of Pfizer. It's a disgruntled investor! Yeah, yeah, that's the ticket! You'd be better off just selling Pfizer' s porn drug, Viagra, and not worrying about competing with Purdue. Purdue is king!
Take your meds. It doesn't take a rocket scientist to conclude that King sold high. The deal was publicly reported, and the lack of billion-dollar-franchise status in Pfizer's hands is public knowledge too. The facts speak for themselves. I don't think this failure was one of the Pfizer operational leads. The market just sucks. You can't sell a product that payers don't want when payers have so many generic options. This was a strategic blunder at a very high level.
Obviously, the above message came from an official source within Pfizer/GCMT. Well then, I guess with words like, "lack of billion dollar franchise status" and "the [opioid abuse deterrent] market just sucks" and "you can't sell a product that payers don't want" and "this was a strategic blunder" - we in the sales force the sales force can expect good things from the approval of ALO-02. Or as Dick Vitale might say, "This is March Madness Baby and the Pfizer coaches can't be sittin around bitching about how underinflated the basketball is. You gotta get out there and shuck and jive, move and groove, dribble and pass, and score points with the Embeda team that got ya here!" Ya hear?
